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A Canker Barking at the Wrong Knee: 
Thyronectria austroamericana Septic 
Arthritis
Sasinuch Rutjanawech, Carlos Mejia-Chew, Chapelle Ayres, and Andrej Spec
Division of Infectious Diseases, Washington University School of Medicine in St Louis, St 
Louis, Missouri, USA
The mold Thyronectria austroamericana is a plant pathogen that 
causes canker in honey locust trees. We describe the first case of 
this mold causing septic arthritis in humans.
Keywords.  fungal septic arthritis; Thyronectria 
austroamericana.
CASE REPORT
A 78-year-old man from Missouri with a history of hyperten-
sion, coronary artery disease, and poorly controlled diabetes 
mellitus presented to the hospital with worsening left knee pain 
with warmth and swelling over the past 2 months. Notably, he 
had twisted his left knee 6 months previously, resulting in mild 
pain and swelling. The patient did not recall having any pene-
trating wound or skin tears, but noted he is an avid gardener 
who often kneels on mulch without any protection. Radiographs 
at the time showed a moderate joint effusion and his symptoms 
initially improved with analgesics. However, 2 months prior to 
presentation, his symptoms progressed. Physical examination 
revealed tenderness, decreased range of motion, and effusion 
of the left knee. This prompted an arthrocentesis that found 
straw-colored, cloudy fluid with 25 223 nucleated cells/µL (77% 
neutrophils), and no crystals or organisms on the Gram stain. 
Fluid culture showed no growth, and he was treated with an 
intra-articular steroid injection. However, symptoms persisted, 
and he developed a flexion contracture that led to the current 
visit. A new arthrocentesis was performed and showed 50 206 
nucleated cells/µL (70% neutrophils). Within 48 hours the aer-
obic culture grew an unidentified mold, initially suspected to 
be a contaminant. A  confirmatory arthrocentesis to exclude 
the existence of a true pathogen again grew mold. Magnetic 
resonance imaging of the knee showed medial and lateral me-
niscus tears with synovial hypertrophy compatible with syno-
vitis, and a moderate to large effusion. The patient underwent 
arthroscopic debridement and intraoperative findings were 
significant for purulent synovial fluid, fibrin, and debris at the 
suprapatellar pouch and throughout the knee, plus a tear of me-
dial and lateral meniscus. There were numerous small white 
spots lining the synovium (Figure 2A). Histopathology of the 
synovial tissue showed multinucleated giant cells mixed with a 
neutrophilic infiltrate. The Gomori methenamine silver stain 
revealed nonpigmented fragmented hyphal fungal forms that 
appeared to be septate and branched at 45 to 90 degrees (Figure 
2B). Multiple intraoperative synovial fluid and tissue samples 
were sent for fungal cultures and all grew a mold, later identi-
fied as Thyronectria austroamericana, using Sanger sequencing 
(D2 rDNA target) with 100% match (National Center for 
Biotechnology Information, GenBank library). Susceptibility 
testing showed minimum inhibitory concentrations of 0.06 µg/
mL for itraconazole and >8 µg/mL for micafungin. All blood 
cultures were negative, and a fourth-generation human immu-
nodeficiency virus test was nonreactive.
The patient was initially treated with liposomal amphotericin 
B 3 mg/kg/day for 7 weeks and later transitioned to itraconazole 
oral solution without reported side effects. However, after 4 
weeks of itraconazole, his symptoms worsened despite good 
adherence and therapeutic serum drug level (1.3 and 1.9  µg/
mL). Because of poor response, itraconazole was changed to 
isavuconazole for preferable pharmacokinetics. Unfortunately, 
there was some delay initiating isavuconazole due to finan-
cial issues (clinical timeline as illustrated in Figure 1). After 
starting isavuconazole, the patient had progressive improve-
ment without any side effects. After 12  months of treatment, 
he achieved complete resolution of the pain and swelling and 
regained normal function of his left knee. Thus, isavuconazole 
was discontinued. At the 6-month follow-up, the patient re-
mains symptom free.
DISCUSSION
Fungal infection is an uncommon cause of chronic septic arthritis 
but is increasingly seen in immunocompromised or chronically 
ill patients, although it may sometimes occur in normal hosts 
[1]. The most common organisms causing septic fungal arthritis 
are Candida and Aspergillus species [2–4]. Despite being an ex-
tremely rare cause of septic arthritis, molds other than Aspergillus 
have been reported as potential emerging pathogens [4]. 
A prior systematic review of osteoarticular infections caused by 
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non-Aspergillus filamentous fungi found hyaline hyphomycetes 
to be the most common etiologic agent (67%), followed by 
dematiaceous mold (17%) and mucormycetes (16%) [4].
The mold Thyronectria austroamericana (homotypic syn-
onym Pleonectria austroamericana, Nectria austroamericana) is 
in the family Nectriaceae, which includes about 20 genera and is 
a well-known plant pathogen that causes canker in honey locust 
(Gleditsia triacanthos; Figure 2C) [5–7].
In plants, the infection caused by this organism manifests as 
sunken, dead areas of bark (Figure 2D), die-back, reduced or 
yellow foliage, premature fall coloration, and early leaf drop [7]. 
It is noteworthy that the honey locust tree is native to central 
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Figure 1. Clinical timeline. Abbreviations: MRI, magnetic resonance imaging; PMN, polymorphonuclear cells.
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Figure 2. A, Arthroscopic findings with numerous small white spots lining the synovium. B, Gomori methenamine silver stain of synovial tissue (photo courtesy of Dr Edward 
Bolesta, reproduced with permission). C, Honey locust tree (photo courtesy of Missouri Botanical Garden, reproduced with permission). D, Canker disease in honey locust 
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North America, and Missouri is in the natural range of distri-
bution of this plant [8, 9]. Although this particular species has 
only been found in America, an asexual morph has also been 
described in Europe [6]. To the best of our knowledge, this is 
the first case report of this mold causing human infection.
The localization of the septic arthritis in this patient’s knee is 
consistent with the most common joint involved in other cases 
of mold septic arthritis [1, 4, 10]. Further interview revealed 
that the patient had a honey locust tree in his backyard, where 
he often spent time kneeling while cultivating vegetables at his 
garden. Although the patient was not severely immunosup-
pressed, he had poorly controlled diabetes and had received an 
intra-articular steroid injection, which are known predisposing 
factors for fungal septic arthritis [1, 2, 11–13]. We hypothe-
size that he acquired the infection through direct inoculation, 
with an unrecognized minor penetrating injury serving as a 
portal of entry. Subsequent intra-articular steroid injection hin-
dered the local immune response, creating the perfect milieu 
for worsening infection. Presumably, underlying poorly con-
trolled diabetes leading to impaired cellular immunity is partly 
contributing.
Treatment of fungal arthritis often requires a combination of 
surgical debridement and prolonged antifungal therapy [1, 3, 
4, 10, 13]. Amphotericin B has been the drug of choice of most 
fungal infections for several decades, but its toxic effects and lack 
of an equivalent oral form often limit its long-term use [3, 14]. 
Among triazoles, voriconazole combined with surgical inter-
vention is the standard treatment for Aspergillus osteomyelitis 
and septic arthritis. Itraconazole and posaconazole have also 
been effectively used in a wide range of rare mold osteoarticular 
infections, as described in case reports [4, 14–17].
Isavuconazole (the active form of prodrug isavuconazonium 
sulfate) is a newer triazole, which is active against a broad spec-
trum of clinically important fungi, including in vitro activity 
against some hyaline and dematiaceous molds [18]. It was ap-
proved by the US Food and Drug Administration in March 
2015 for the treatment of adults with invasive aspergillosis and 
mucormycosis. Compared to voriconazole, it has more predict-
able pharmacokinetics with low interpatient variability and less 
adverse skin, hepatobiliary, and visual side effects [19]. Unlike 
other triazoles, most studies have not shown an association with 
isavuconazole and QTc prolongation [20]. To date, there has not 
been a report of non-Aspergillus, non-Mucorales mold arthritis 
specifically treated by isavuconazole. Nevertheless, based on 
the mechanism of action, pharmacological properties, and pre-
vious clinical studies [19, 21, 22], we reasonably believed that T 
austroamericana was effectively treated by isavuconazole. The 
clinical response seen in our patient supports our hypothesis.
CONCLUSIONS
Molds are an extremely rare cause of septic arthritis, usu-
ally seen in immunosuppressed patients, but can be found 
in immunocompetent hosts with chronic comorbidities. 
Thyronectria austroamericana is first described here as an un-
usual cause of septic arthritis in humans. Successful treatment 
was achieved by surgical debridement in combination with pro-
longed antifungal therapy. Isavuconazole following induction 
with amphotericin B proved to be an effective and well-tolerated 
step-down for consolidation in this unusual mold infection.
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